LacriJet

LacriJet® is a preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time, eitherin the intubation phase as well as forthe removal of the device. LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knots and no sutures are needed. The smaller sizes LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.

• Diameter: 0.64mm
• Material: Silicone
• Requires sizer (S1.1288) to select the length & 0.3mm disposable punctum dilator and plug inserter (S1.3090)

FCI Ophthalmics is a specialty medical device company focused on developing and supplying innovative surgical products for ophthalmology, particularly in the areas of oculoplastics, lacrimal surgery, and retina. The company offers a broad portfolio that includes lacrimal stents and intubation systems, orbital implants, eyelid weights, punctal plugs, and devices for retinal and vitreoretinal procedures. Known for products like the Monoka stent, the BIKA intubation system, and the TearStim dry eye treatment device, FCI supports ophthalmic surgeons with precise, minimally invasive solutions designed to restore function and improve patient comfort in both reconstructive and functional eye surgeries.